Healthcare (SH:603313) Xin Lang Cai Jing·2026-01-16 09:45Summary of Key Points Core Viewpoint - The major shareholder, Zhongyue Focus No. 9, has completed a share reduction plan, decreasing its stake in Dream Lily from 8.68% to 7.68% after selling 5,700,000 shares for approximately 53.09 million yuan [1] Group 1: Shareholder Actions - Zhongyue Focus No. 9 held 49,504,507 shares before the reduction, representing 8.68% of the total share capital [1] - The initial plan was to reduce holdings by up to 5,705,868 shares, which is not more than 1% of the total share capital, within three months following the announcement on December 13, 2025 [1] - The share reduction occurred between January 8 and January 16, 2026, through a centralized bidding method [1] Group 2: Financial Impact - The total amount raised from the share reduction was 53.09 million yuan [1] - After the completion of the reduction plan, the holding percentage of Zhongyue Focus No. 9 decreased to 7.68% [1]